Inflammatory Bowel Disease
312
28
32
185
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
47 trials with published results (15%)
Research Maturity
185 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
24 terminated out of 312 trials
88.5%
+2.0% vs benchmark
12%
38 trials in Phase 3/4
25%
47 of 185 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 185 completed trials
Clinical Trials (312)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)
A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Immune Regulation in Ulcerative Colitis or Crohn s Disease
A Study to Measure Mirikizumab Levels in Breast Milk of Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease
A Clinical Study of SPH7854 Granules in Healthy Subjects.
Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ?
The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares
A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease
Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inflammatory Bowel Disease Patients
Fecal Microbiome Transplant
Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD
A Clinical Study to Evaluate SM17 in Healthy Participants
Impact of Morning Light Therapy in IBD
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease